Your browser doesn't support javascript.
loading
Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer.
Rodriguez-Aguayo, Cristian; Del C Monroig, Paloma; Redis, Roxana S; Bayraktar, Emine; Almeida, Maria I; Ivan, Cristina; Fuentes-Mattei, Enrique; Rashed, Mohammed H; Chavez-Reyes, Arturo; Ozpolat, Bulent; Mitra, Rahul; Sood, Anil K; Calin, George A; Lopez-Berestein, Gabriel.
Affiliation
  • Rodriguez-Aguayo C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Del C Monroig P; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Redis RS; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bayraktar E; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Almeida MI; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ivan C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fuentes-Mattei E; Instituto de Investigação e Inovação em Saúde/Institute for Research and Innovation in Health (I3S) and Instituto de Engenharia Biomédica (INEB), University of Porto, Porto, Portugal.
  • Rashed MH; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chavez-Reyes A; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ozpolat B; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mitra R; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sood AK; Department of Pharmacology and Toxicology, Faculty of Pharmacy, The University of Al-Azhar, Cairo, Egypt.
  • Calin GA; Center for Research and Advanced Studies, National Polytechnic Institute (CINVESTAV del IPN), Monterrey, Mexico.
  • Lopez-Berestein G; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cell Discov ; 9(1): 111, 2023 Nov 08.
Article in En | MEDLINE | ID: mdl-37940695
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Discov Year: 2023 Document type: Article Affiliation country: United States Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Discov Year: 2023 Document type: Article Affiliation country: United States Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM